About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.

The rocket rumbled as it headed on an eastern trajectory. Just over eight minutes into the flight, the second-stage and satellite were safely in Earth orbit, headed for its final position ...